Effect of platelet-derived growth factor on phosphatidylcholine-hydrolyzing phospholipase d in osteoblast-like cells

Osamu Kozawa, Atsushi Suzuki, Yasuko Watanabe, Junji Shinoda, Yutaka Oiso

研究成果: Article

19 引用 (Scopus)

抄録

We examined the effect of platelet-derived growth factor (PDGF) on the activation of phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like MC3T3-E1 cells. PDGF-BB stimulated both the formation of choline (EC50 = 15 ng/ml) and inositol phosphates (EC50 = 5 ng/ml). However, PDGF-BB had little effect on the formation of phosphocholine. The formation of choline stimulated by a combination of PDGF-BB and 12-O-tetradecanoylphorbol-13-acetate, a protein kinase C (PKC)-activating phorbol ester, was additive. H-7, an inhibitor of protein kinases, inhibited 12-O-tetradecanoylphorbol-13-acetate-induced choline formation, whereas HA1004, a control for H-7 as PKC inhibitor, had little effect. Neither H-7 nor HA1004 affected the PDGF-BB-induced formation of choline. Genistein and methyl 2,5-dihydroxycinnamate, inhibitors of protein tyrosine kinases, dose dependently inhibited the PDGF-BB-induced formation of choline. PDGF-BB stimulated Ca2+ influx from extracellular space. PDGF-BB-induced choline formation was significantly reduced by chelating extracellular Ca2+ with EGTA. PDGF-BB stimulated DNA synthesis of MC3YT3-E1 cells, and H-7 inhibited the DNA synthesis. These results strongly suggest that PDGF activates phosphatidyl-choline-hydrolyzing phospholipase D independently from PKC activated by phosphoinositide hydrolysis in osteoblast-like cells, and that both tyrosine kinase activation and Ca2+ influx are essential for this mechanism.

元の言語English
ページ(範囲)4473-4478
ページ数6
ジャーナルEndocrinology
136
発行部数10
DOI
出版物ステータスPublished - 01-01-1995
外部発表Yes

Fingerprint

Phospholipases
Platelet-Derived Growth Factor
Osteoblasts
Phosphatidylcholines
Choline
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Protein Kinase C
Phospholipase D
Tetradecanoylphorbol Acetate
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Inositol Phosphates
Phosphorylcholine
platelet-derived growth factor BB
Protein C Inhibitor
Genistein
Egtazic Acid
DNA
Extracellular Space
Phorbol Esters

All Science Journal Classification (ASJC) codes

  • Endocrinology

これを引用

Kozawa, Osamu ; Suzuki, Atsushi ; Watanabe, Yasuko ; Shinoda, Junji ; Oiso, Yutaka. / Effect of platelet-derived growth factor on phosphatidylcholine-hydrolyzing phospholipase d in osteoblast-like cells. :: Endocrinology. 1995 ; 巻 136, 番号 10. pp. 4473-4478.
@article{f49463d447ec44a0b6128ad83e1594f1,
title = "Effect of platelet-derived growth factor on phosphatidylcholine-hydrolyzing phospholipase d in osteoblast-like cells",
abstract = "We examined the effect of platelet-derived growth factor (PDGF) on the activation of phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like MC3T3-E1 cells. PDGF-BB stimulated both the formation of choline (EC50 = 15 ng/ml) and inositol phosphates (EC50 = 5 ng/ml). However, PDGF-BB had little effect on the formation of phosphocholine. The formation of choline stimulated by a combination of PDGF-BB and 12-O-tetradecanoylphorbol-13-acetate, a protein kinase C (PKC)-activating phorbol ester, was additive. H-7, an inhibitor of protein kinases, inhibited 12-O-tetradecanoylphorbol-13-acetate-induced choline formation, whereas HA1004, a control for H-7 as PKC inhibitor, had little effect. Neither H-7 nor HA1004 affected the PDGF-BB-induced formation of choline. Genistein and methyl 2,5-dihydroxycinnamate, inhibitors of protein tyrosine kinases, dose dependently inhibited the PDGF-BB-induced formation of choline. PDGF-BB stimulated Ca2+ influx from extracellular space. PDGF-BB-induced choline formation was significantly reduced by chelating extracellular Ca2+ with EGTA. PDGF-BB stimulated DNA synthesis of MC3YT3-E1 cells, and H-7 inhibited the DNA synthesis. These results strongly suggest that PDGF activates phosphatidyl-choline-hydrolyzing phospholipase D independently from PKC activated by phosphoinositide hydrolysis in osteoblast-like cells, and that both tyrosine kinase activation and Ca2+ influx are essential for this mechanism.",
author = "Osamu Kozawa and Atsushi Suzuki and Yasuko Watanabe and Junji Shinoda and Yutaka Oiso",
year = "1995",
month = "1",
day = "1",
doi = "10.1210/endo.136.10.7664667",
language = "English",
volume = "136",
pages = "4473--4478",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "10",

}

Effect of platelet-derived growth factor on phosphatidylcholine-hydrolyzing phospholipase d in osteoblast-like cells. / Kozawa, Osamu; Suzuki, Atsushi; Watanabe, Yasuko; Shinoda, Junji; Oiso, Yutaka.

:: Endocrinology, 巻 136, 番号 10, 01.01.1995, p. 4473-4478.

研究成果: Article

TY - JOUR

T1 - Effect of platelet-derived growth factor on phosphatidylcholine-hydrolyzing phospholipase d in osteoblast-like cells

AU - Kozawa, Osamu

AU - Suzuki, Atsushi

AU - Watanabe, Yasuko

AU - Shinoda, Junji

AU - Oiso, Yutaka

PY - 1995/1/1

Y1 - 1995/1/1

N2 - We examined the effect of platelet-derived growth factor (PDGF) on the activation of phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like MC3T3-E1 cells. PDGF-BB stimulated both the formation of choline (EC50 = 15 ng/ml) and inositol phosphates (EC50 = 5 ng/ml). However, PDGF-BB had little effect on the formation of phosphocholine. The formation of choline stimulated by a combination of PDGF-BB and 12-O-tetradecanoylphorbol-13-acetate, a protein kinase C (PKC)-activating phorbol ester, was additive. H-7, an inhibitor of protein kinases, inhibited 12-O-tetradecanoylphorbol-13-acetate-induced choline formation, whereas HA1004, a control for H-7 as PKC inhibitor, had little effect. Neither H-7 nor HA1004 affected the PDGF-BB-induced formation of choline. Genistein and methyl 2,5-dihydroxycinnamate, inhibitors of protein tyrosine kinases, dose dependently inhibited the PDGF-BB-induced formation of choline. PDGF-BB stimulated Ca2+ influx from extracellular space. PDGF-BB-induced choline formation was significantly reduced by chelating extracellular Ca2+ with EGTA. PDGF-BB stimulated DNA synthesis of MC3YT3-E1 cells, and H-7 inhibited the DNA synthesis. These results strongly suggest that PDGF activates phosphatidyl-choline-hydrolyzing phospholipase D independently from PKC activated by phosphoinositide hydrolysis in osteoblast-like cells, and that both tyrosine kinase activation and Ca2+ influx are essential for this mechanism.

AB - We examined the effect of platelet-derived growth factor (PDGF) on the activation of phosphatidylcholine-hydrolyzing phospholipase D in osteoblast-like MC3T3-E1 cells. PDGF-BB stimulated both the formation of choline (EC50 = 15 ng/ml) and inositol phosphates (EC50 = 5 ng/ml). However, PDGF-BB had little effect on the formation of phosphocholine. The formation of choline stimulated by a combination of PDGF-BB and 12-O-tetradecanoylphorbol-13-acetate, a protein kinase C (PKC)-activating phorbol ester, was additive. H-7, an inhibitor of protein kinases, inhibited 12-O-tetradecanoylphorbol-13-acetate-induced choline formation, whereas HA1004, a control for H-7 as PKC inhibitor, had little effect. Neither H-7 nor HA1004 affected the PDGF-BB-induced formation of choline. Genistein and methyl 2,5-dihydroxycinnamate, inhibitors of protein tyrosine kinases, dose dependently inhibited the PDGF-BB-induced formation of choline. PDGF-BB stimulated Ca2+ influx from extracellular space. PDGF-BB-induced choline formation was significantly reduced by chelating extracellular Ca2+ with EGTA. PDGF-BB stimulated DNA synthesis of MC3YT3-E1 cells, and H-7 inhibited the DNA synthesis. These results strongly suggest that PDGF activates phosphatidyl-choline-hydrolyzing phospholipase D independently from PKC activated by phosphoinositide hydrolysis in osteoblast-like cells, and that both tyrosine kinase activation and Ca2+ influx are essential for this mechanism.

UR - http://www.scopus.com/inward/record.url?scp=0029083616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029083616&partnerID=8YFLogxK

U2 - 10.1210/endo.136.10.7664667

DO - 10.1210/endo.136.10.7664667

M3 - Article

VL - 136

SP - 4473

EP - 4478

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 10

ER -